CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection

Jing Wei, Jing Peng, Bing Wang, Hong Qu, Shiyi Wang, Aziz Faisal, Jia Wei Cheng, John R. Gordon, Fang Li

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Klebsiella pneumoniae-associated pathology is largely mediated by neutrophilic inflammation. In this study, we administered Klebsiella pneumoniae to experimental guinea pig groups and the ELR-CXC chemokine antagonist CXCL8 3 - 72, ceftazidime, and dexamethasone to different groups, respectively. After 24 h, we assessed the animal's pulmonary inflammatory levels, including gross histopathology, airway neutrophilia, lung myeloperoxidase levels, expressions of CXCL8 and TNF, and airway bacterial loads. Compared with ceftazidime and dexamethasone treatments, the administration of the ELR-CXC chemokine antagonist CXCL8 3 - 72 alone was more effective than other methods, although it did not markedly attenuate the bacterial load. These results suggest new methods for the treatment of Klebsiella pneumoniae pathology.

Original languageEnglish (US)
Article number720975
JournalBioMed Research International
Volume2013
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection'. Together they form a unique fingerprint.

Cite this